JP2010529144A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010529144A5 JP2010529144A5 JP2010511389A JP2010511389A JP2010529144A5 JP 2010529144 A5 JP2010529144 A5 JP 2010529144A5 JP 2010511389 A JP2010511389 A JP 2010511389A JP 2010511389 A JP2010511389 A JP 2010511389A JP 2010529144 A5 JP2010529144 A5 JP 2010529144A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- fluoro
- optionally substituted
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003118 aryl group Chemical group 0.000 claims 35
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 32
- 125000001153 fluoro group Chemical group F* 0.000 claims 22
- 239000001257 hydrogen Substances 0.000 claims 21
- 229910052739 hydrogen Inorganic materials 0.000 claims 21
- 150000001875 compounds Chemical class 0.000 claims 20
- 239000000203 mixture Substances 0.000 claims 20
- 125000000217 alkyl group Chemical group 0.000 claims 15
- 125000000623 heterocyclic group Chemical group 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 14
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 13
- 241001465754 Metazoa Species 0.000 claims 11
- 125000005843 halogen group Chemical group 0.000 claims 10
- 150000002431 hydrogen Chemical class 0.000 claims 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 9
- 125000001072 heteroaryl group Chemical group 0.000 claims 9
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 8
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 6
- 208000010877 cognitive disease Diseases 0.000 claims 6
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 6
- 239000001301 oxygen Substances 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 4
- -1 Ring Chemical group 0.000 claims 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 4
- 230000015654 memory Effects 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000002757 morpholinyl group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 229910003827 NRaRb Inorganic materials 0.000 claims 1
- 230000003920 cognitive function Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000007787 long-term memory Effects 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000006403 short-term memory Effects 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 0 O=C(N(CC1)CCN1c1ccccc1)N(C=C1C(c2c3)=N*C(c4ccccc4)C1=O)c2ccc3F Chemical compound O=C(N(CC1)CCN1c1ccccc1)N(C=C1C(c2c3)=N*C(c4ccccc4)C1=O)c2ccc3F 0.000 description 7
- QPVPWQAYVUZOGI-UHFFFAOYSA-N CN(CC1)CCN1C(N(C=C(C(c1c2)=NN3c4ccccc4)C3=O)c1ccc2OC)=O Chemical compound CN(CC1)CCN1C(N(C=C(C(c1c2)=NN3c4ccccc4)C3=O)c1ccc2OC)=O QPVPWQAYVUZOGI-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94299207P | 2007-06-08 | 2007-06-08 | |
| PCT/US2008/066205 WO2008154442A1 (en) | 2007-06-08 | 2008-06-06 | Therapeutic pyrazoloquinoline urea derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010529144A JP2010529144A (ja) | 2010-08-26 |
| JP2010529144A5 true JP2010529144A5 (enExample) | 2011-07-14 |
Family
ID=40096439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010511389A Pending JP2010529144A (ja) | 2007-06-08 | 2008-06-06 | 治療用ピラゾロキノリン尿素誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7863266B2 (enExample) |
| EP (1) | EP2164328B8 (enExample) |
| JP (1) | JP2010529144A (enExample) |
| KR (1) | KR20100038189A (enExample) |
| CN (1) | CN101686682A (enExample) |
| AU (1) | AU2008261888A1 (enExample) |
| BR (1) | BRPI0812347A2 (enExample) |
| CA (1) | CA2688405A1 (enExample) |
| ES (1) | ES2433566T3 (enExample) |
| IL (1) | IL202286A0 (enExample) |
| MX (1) | MX2009013205A (enExample) |
| WO (1) | WO2008154442A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8927546B2 (en) * | 2006-02-28 | 2015-01-06 | Dart Neuroscience (Cayman) Ltd. | Therapeutic piperazines |
| AU2008261888A1 (en) * | 2007-06-08 | 2008-12-18 | Helicon Therapeutics, Inc. | Therapeutic pyrazoloquinoline urea derivatives |
| US8895580B2 (en) | 2009-10-21 | 2014-11-25 | Merck Sharp & Dohme Corp. | Quinolinone-pyrazolone M1 receptor positive allosteric modulators |
| US9468662B2 (en) | 2010-07-12 | 2016-10-18 | Orphit | Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases |
| FR2962335B1 (fr) * | 2010-07-12 | 2013-01-18 | Cll Pharma | Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| CN106187887B (zh) * | 2016-07-01 | 2018-08-14 | 上海工程技术大学 | 4-羟基喹啉-3-甲酸的制备方法 |
| MX2019005569A (es) | 2016-11-11 | 2019-09-05 | Bayer Animal Health Gmbh | Nuevos derivados de quinolina. |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE8629T1 (de) * | 1979-06-21 | 1984-08-15 | Ciba-Geigy Ag | Pyrazolochinoline, verfahren zu ihrer herstellung, und pharmazeutische praeparate enthaltend diese verbindungen. |
| DE3204126A1 (de) * | 1982-02-06 | 1983-08-11 | Bayer Ag, 5090 Leverkusen | Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US4524146A (en) * | 1982-12-08 | 1985-06-18 | Ciba-Geigy Corporation | Certain -2-heterocycle substituted pyrazoloquinolines |
| US4814450A (en) * | 1984-07-09 | 1989-03-21 | Ciba-Geigy Corporation | Certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives |
| JPS61112075A (ja) * | 1984-11-05 | 1986-05-30 | Shionogi & Co Ltd | チエニルピラゾロキノリン誘導体 |
| EP0214092A1 (en) | 1985-08-08 | 1987-03-11 | Ciba-Geigy Ag | Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone |
| EP0590022A1 (en) * | 1991-06-14 | 1994-04-06 | PHARMACIA & UPJOHN COMPANY | IMIDAZO 1,5-a]QUINOXALINES |
| US5334595A (en) * | 1992-10-23 | 1994-08-02 | Sterling Winthrop Inc. | Pyrazoloquinolones as anticancer agents |
| US5792766A (en) * | 1996-03-13 | 1998-08-11 | Neurogen Corporation | Imidazo 1,5-c! quinazolines; a new class of GABA brain receptor ligands |
| GB9716347D0 (en) * | 1997-08-01 | 1997-10-08 | Merck Sharp & Dohme | Therapeutic compounds |
| GB9716344D0 (en) * | 1997-08-01 | 1997-10-08 | Merck Sharp & Dohme | Therapeutic compounds |
| GB9716345D0 (en) * | 1997-08-01 | 1997-10-08 | Merck Sharp & Dohme | Therapeutic compounds |
| TWI271406B (en) * | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| ATE337322T1 (de) * | 2001-02-21 | 2006-09-15 | Janssen Pharmaceutica Nv | Isoxazolin-derivate als antidepressiva |
| JP3896309B2 (ja) * | 2001-07-09 | 2007-03-22 | ファイザー株式会社 | プロテインキナーゼｃ阻害物質としてのピラゾロキノリノン誘導体 |
| US7674906B2 (en) * | 2002-12-16 | 2010-03-09 | Active Biotech Ab | Tetracyclic immunomodulatory compounds |
| TW200508233A (en) * | 2003-05-29 | 2005-03-01 | Millennium Pharm Inc | Chk-1 inhibitors |
| US7544697B2 (en) * | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| CA2621560A1 (en) * | 2005-09-07 | 2007-03-15 | Braincells, Inc. | Modulation of neurogenesis by hdac inhibition |
| EP2612854B1 (en) * | 2005-10-25 | 2015-04-29 | Shionogi&Co., Ltd. | Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors |
| AU2008261888A1 (en) * | 2007-06-08 | 2008-12-18 | Helicon Therapeutics, Inc. | Therapeutic pyrazoloquinoline urea derivatives |
| ATE544344T1 (de) * | 2007-06-08 | 2012-02-15 | Helicon Therapeutics Inc | Therapeutische pyrazolochinolinderivate |
| ES2483728T3 (es) * | 2007-06-08 | 2014-08-07 | Dart Neuroscience (Cayman) Ltd | Derivados terapéuticos de pirazolonafatiridina |
-
2008
- 2008-06-06 AU AU2008261888A patent/AU2008261888A1/en not_active Abandoned
- 2008-06-06 JP JP2010511389A patent/JP2010529144A/ja active Pending
- 2008-06-06 CN CN200880023876A patent/CN101686682A/zh active Pending
- 2008-06-06 CA CA002688405A patent/CA2688405A1/en not_active Abandoned
- 2008-06-06 KR KR1020107000233A patent/KR20100038189A/ko not_active Withdrawn
- 2008-06-06 WO PCT/US2008/066205 patent/WO2008154442A1/en not_active Ceased
- 2008-06-06 MX MX2009013205A patent/MX2009013205A/es active IP Right Grant
- 2008-06-06 US US12/135,023 patent/US7863266B2/en not_active Expired - Fee Related
- 2008-06-06 BR BRPI0812347A patent/BRPI0812347A2/pt not_active IP Right Cessation
- 2008-06-06 ES ES08770406T patent/ES2433566T3/es active Active
- 2008-06-06 EP EP08770406.0A patent/EP2164328B8/en not_active Not-in-force
-
2009
- 2009-11-23 IL IL202286A patent/IL202286A0/en unknown
-
2010
- 2010-11-29 US US12/955,792 patent/US8343957B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010529144A5 (enExample) | ||
| CY1124117T1 (el) | Ετεροκυκλικες αλκυνυλοβενζολικες ενωσεις και ιατρικες συνθεσεις και χρησεις αυτων | |
| JP2017537940A5 (enExample) | ||
| JP2015143283A5 (enExample) | ||
| JP2008505194A5 (enExample) | ||
| MX2009012613A (es) | Tiazoles substituidos por heteroarilo y su uso como agentes antivirales. | |
| EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
| JP2015531747A5 (enExample) | ||
| WO2008057855A9 (en) | Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity | |
| JP2013510178A5 (enExample) | ||
| JP2011509949A5 (enExample) | ||
| MA37400A1 (fr) | Composés hétérocyclyle en tant qu'inhibiteurs de mek | |
| JP2012097115A5 (enExample) | ||
| RU2012125971A (ru) | Новые химические соединения производные 2,4-диамино-1,3,5-триазина для профилактики и лечения заболеваний человека и животных | |
| JP2012512863A5 (enExample) | ||
| JP2014511366A5 (enExample) | ||
| HRP20210158T1 (hr) | Postupak i sustav za premještanje fluida iz posude za opskrbu u komponentu za isporuku | |
| JP2012509265A5 (enExample) | ||
| JP2010529143A5 (enExample) | ||
| PE20090295A1 (es) | Derivados de espirociclopropilpiperidina | |
| EA200800502A1 (ru) | Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения | |
| JP2013522207A5 (enExample) | ||
| JP2009525987A5 (enExample) | ||
| PE20150708A1 (es) | Derivados de ariletinilo | |
| EA200802000A1 (ru) | Фармацевтически приемлемые соли и полиморфные формы |